Glucocorticoid induced receptor (hgir,rp-23) ligand screening

Details Glucocorticoid induced receptor (hgir,rp-23) ligand screening Glucocorticoid induced receptor (hgir,rp-23) ligand screening

G - Physics

01

N

G01N 33/567 (2006.01) C07K 14/72 (2006.01) C12Q 1/68 (2006.01) G01N 33/92 (2006.01)

Patent

CA 2395175

The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists of sphingosine-1 PO4. The assays are based upon the binding of sphingosine-1 PO4 to the RP-23 receptor.

La présente invention se rapporte à des analyses permettant de détecter des composés qui ont une action agoniste ou antagoniste vis à vis de la sphingosine-1 PO¿4?. Ces analyses sont fondées sur la liaison de la sphingosine-1 PO¿4? Au récepteur RP-23.

Affiliated with

Also associated with

Rating

Glucocorticoid induced receptor (hgir,rp-23) ligand screening does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucocorticoid induced receptor (hgir,rp-23) ligand screening, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocorticoid induced receptor (hgir,rp-23) ligand screening will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1435727